Dr. Karl-Rudolf Erlemann

I am VP of Business Development and External Scientific affairs at InSymbiosis, a strategic drug development partner for the biopharma industry with a unique collaborative business model. We utilize functional outsourcing, relying on the use of CROs and CMOs as vendors and collaborate with academic partners, to develop novel medications. In this position I find new vendors to execute development programs, look for new investment opportunities and perform the scientific due diligence.

I manage a significant number of drug development programs using a functional outsourcing model. Here I oversee programs from early discovery to phase 1 for small molecules, peptides, antibodies, proteins and antisense drugs across a diverse range of molecular targets and disease indications.

As Project Director at InSymbiosis I provided research services and collaborative research opportunities to the global pharmaceutical and biotechnology industries. The main focus was on the development of a new business model based on functional outsourcing.

As Research Scientist I oversaw all standard in vitro drug metabolism and ADME studies. In addition, I was responsible for the good laboratory practice (GLP) compliance of the labs. I standardized the work flow and documentation and was the single point of contact for the Quality Assurance Unit.

Oxidative Stress Inflammation HPLC-Method development Cell Culture Immunology

Molecular Biophysics